Head-to-head · WeighScore
Oak vs The Edit
The verdict
The Edit takes it — 70.4/100 to 63.2/100.
The Edit grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. The Edit holds one price at every dose, charges nothing to start, refunds in full if you are not approved, and then says none of its published policies actually govern.
We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.
Factor by factor
The same six graded dimensions, side by side. See the methodology.
The numbers
| Metric | Oak | The Edit |
|---|---|---|
| WeighScore | 63.2/100 | 70.4/100 |
| Grade | C | C |
| Site position | #221 | #118 |
| Semaglutide | $250/mo (one flat rate at every dose), read on its order form the afternoon of 15 August; it showed $200/mo that morning | $259/mo (standing rate, flat at every dose; $200 covers the first month only) |
| Tirzepatide | $300/mo (one flat rate at every dose), read on its order form the afternoon of 15 August; it showed $250/mo that morning | $349/mo (standing rate, flat at every dose; $300 covers the first month only) |
| Coverage | All 50 states | All 50 states (claimed; hedged in the same paragraph, no list published) |
| Brand-name access | Compounded only | Compounded only |
| Oral / sublingual | Injection only | Injection only |
Site position #221 · C
Strengths
- No membership or subscription fee, and free shipping
- All 50 states, offered in Spanish as well as English
- One price at every dose, so titrating up does not cost more — its order form states it as "One price · All dosages" beside the figure itself
- The price is reachable without handing over any medical detail: the figures sit on the first screen of its order form, before a single question is answered
Where it loses points
- Its advertising and its order form disagree: none of the nine "starting" figures it markets is the $200/$250 it actually charges, so anyone comparing on the advertised numbers is comparing against a price Oak does not offer
- Nine conflicting "starting" figures appear across Oak's own pages — $119, $133, $160, $167, $180, $185, $190, $199 and $250 — and none carries a term or a billing cadence. Its headline "$133 / $199" is the three-month prepay under code OAKSAVE200, billed upfront, not a monthly rate
- The cheapest two, "$119" and "$185", sit beside a "$200 off" new-patient offer that Oak elsewhere describes as "$50 off your first month, $200 off 3-months" — a three-month package discount, not a monthly rate
- Its two comparison tables disagree with each other and with its two FAQs: $167/mo against $190/mo, "as little as $119/month" against "as little as $190/month or lower"
- Worth re-checking at the last step: an earlier reading of its checkout copy recorded dose steps costing roughly $50–$75 more, which its order form's "One price · All dosages" line contradicts
- Same-day approval with no video call means very little clinical contact before a prescription
- No published lab or monitoring program
- Injection only, and no brand-name lane
- Sold as packages, so re-ordering is on you
Site position #118 · C
Strengths
- The price is flat at every dose with no titration ladder, so the figure a reader sees is the figure at maintenance
- Nothing is charged and no card is taken to begin, and a full refund applies if a clinician does not approve treatment
- Names its medical director with an NPI number and the medical practice behind him, and names a dispensing pharmacy
- Prescription medication, injection supplies, the clinician visit and ongoing care are itemized as included, with no membership fee
- A separate hormone menu is priced beside the GLP-1 lines
Where it loses points
- $200 and $300 are first-order promotional prices printed larger than the struck standing rates of $259 and $349, and the promotion carries no end date and no code
- The published cancellation and refund policies say the Membership Agreement controls where they differ, and that nothing on the public site is binding — so the terms a reader can read are not the terms that apply
- Two-day shipping is transit time only; the site's own shipping policy states an average of 4 to 12 business days from prescription
- “Available in all 50 U.S. states” is hedged in the same paragraph and no state list is published anywhere
- The three- and six-month figures are one charge, not a monthly rate, and the per-month numbers beside them are arithmetic rather than billing
- The named pharmacy is described as one member of a plural pharmacy network whose other members are not named
- No compounding class is stated, and whether a separate visit fee is ever charged is not answered
Featured provider
Oak
Oak scores 63.2/100 (C). Charges $200/mo for compounded semaglutide and $250 for tirzepatide, one flat rate at every dose — but you will not find those figures in its advertising, where nine different "starting" prices appear across its own pages and not one of them is what it charges.
Commercial relationships affect this placement. The score comparison above is separate.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.